WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (55)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Restituito, S.
Right arrow Articles by Charnet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Restituito, S.
Right arrow Articles by Charnet, P.

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 15, 2000, 20(24):9046-9052

The beta 2a Subunit Is a Molecular Groom for the Ca2+ Channel Inactivation Gate

S. Restituito1, T. Cens1, C. Barrere1, S. Geib2, S. Galas1, M. De Waard2, and P. Charnet1

1 Centre de Recherches de Biochimie Macromoléculaire, Centre National de la Recherche Scientifique, Unité Propre de Recherche 1086, Institut Fédératif de Recherche 24, 34293 Montpellier Cedex 05, France, and 2 Institut National de la Santé et de la Recherche Médicale U464, Institut Fédératif Jean Roche, Laboratoire de Neurobiologie des Canaux Ioniques, 13916 Marseille Cedex 20, France


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Ca2+ channel inactivation is a key element in controlling the level of Ca2+ entry through voltage-gated Ca2+ channels. Interaction between the pore-forming alpha 1 subunit and the auxiliary beta  subunit is known to be a strong modulator of voltage-dependent inactivation. Here, we demonstrate that an N-terminal membrane anchoring site (MAS) of the beta 2a subunit strongly reduces alpha 1A (CaV2.1) Ca2+ channel inactivation. This effect can be mimicked by the addition of a transmembrane segment to the N terminus of the beta 2a subunit. Inhibition of inactivation by beta 2a also requires a link between MAS and another important molecular determinant, the beta  interaction domain (BID). Our data suggest that mobility of the Ca2+ channel I-II loop is necessary for channel inactivation. Interaction of this loop with other identified intracellular channel domains may constitute the basis of voltage-dependent inactivation. We thus propose a conceptually novel mechanism for slowing of inactivation by the beta 2a subunit, in which the immobilization of the channel inactivation gate occurs by means of MAS and BID.

Key words: P/Q type Ca2+ channels; CaV2.1; beta subunit; inactivation mechanism; palmitoylation; membrane anchoring; I-II loop


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Ca2+ channels beta  subunits are intracellular proteins associated in vivo with high voltage-activated Ca2+ channel alpha 1 subunits, which finely tune many of their electrophysiological and kinetic properties (Berrow et al., 1997). Ten different genes encode voltage-gated Ca2+ channel alpha 1 subunits (Randall and Benam, 1999). All of them, except the T-type Ca2+ channels (Randall and Benam, 1999), can interact with one of four different beta  subunits (beta 1-beta 4) (Birnbaumer et al., 1998; Walker and De Waard, 1998). Within the same type of pharmacologically defined Ca2+ channels, these beta  subunits represent a major determinant of variability in channel properties. beta 1, beta 3, and beta 4 subunits induce hyperpolarizing shifts in the activation and inactivation properties of these channels and accelerate their activation kinetics and voltage- and Ca2+-dependent inactivation (Varadi et al., 1991; Neely et al., 1993; Sather et al., 1993; Stea et al., 1993; Jones et al., 1998). The beta 2a subunit plays a different role because it slows down voltage- and Ca2+-dependent inactivation (Sather et al., 1993; Stea et al., 1994; Jones et al., 1998) and is unable to confer prepulse facilitation to the L-type Ca2+ channel (Cens et al., 1996). Sequence homology analysis of these different beta  subunits reveals the existence of two well conserved domains in their primary sequence (C1, C2), surrounded by more variable regions in which alternative splicing occurs (V1-V3) (Fig. 1) (Perez Reyes and Schneider, 1994). The conserved site of interaction between the alpha 1 and the beta  subunits has been mapped to the beginning of the C2 domain of beta  (De Waard et al., 1994; Walker and De Waard, 1998). This site interacts with a consensus beta  subunit-binding sequence [alpha interaction domain (AID)] localized on the loop connecting domain I and II of the alpha 1 subunit (Pragnell et al., 1994; De Waard et al., 1995). The specificity of the effects of the beta 2a subunit is mediated, as least in part, by two cysteines located at the N terminal end of some isoforms of the beta 2a subunits (Fig. 1) (Chien et al., 1996; Qin et al., 1998). Similar to alpha s GTP-binding proteins, these cysteines are post-translationally modified through the addition of thioester-bound palmitic acids and thus allow a membrane association of the beta 2a subunit (Chien et al., 1998) and regulation of the inactivation of the alpha 1E subunit (Qin et al., 1998). However, the partial data available have not yet allowed the elucidation of the molecular mechanisms by which these palmitoylated cysteines slow inactivation.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 1.   A, Schematic representation of the Ca2+ channel beta  subunit. V1, V2, and V3 represent regions of variable sequences among the different beta  subunits. C1 and C2 are regions of high homology. Drawing has been scaled according to beta 2a sequence, and the box represents the V1 sequence. Amino acid alignment of the N-terminal tail of the beta 1 and beta 2 subunits. Note the presence of the two Cys residues in the rat beta 2 subunit. B, Left, Rapidly and slowly inactivating Ba2+ currents recorded from oocytes expressing the alpha 1A plus alpha 2-delta calcium channel subunits with, respectively, the beta 1 or the beta 2 subunits. Inactivation was quantified by the percent of inactivation measured at the end of a 2.5 sec test pulse to +10 mV. Right, Confocal immunofluorescent images of beta  subunit-transfected tsA 201 cells were obtained after fixation and immunohistochemical staining using a beta -com primary antibody. Note the membrane localization of the beta 2a subunit while the beta 1 subunit is localized to the cytoplasm.

In this work, we have expressed several mutated forms of the beta 1 and beta 2 subunits in Xenopus oocytes and tsA 201 cells and analyzed in parallel (1) their effects on the inactivation of P/Q type Ca2+ channels, and (2) their subcellular localization when expressed alone. Our results strongly suggest that the beta 2a subunit acts as an anchor for the Ca2+ channel I-II loop proposed to be an inactivation particle, thus reducing inactivation. We show that several intracellular domains of the alpha 1A (CaV2.1) channel can interact with the I-II loop and are thus potential receptor sites for the inactivation particle.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Preparation of mutated beta  subunits. The following calcium channel subunits were used: alpha 1A (Starr et al., 1991), beta 1b (Pragnell et al., 1991), beta 2a (Perez Reyes et al., 1992), and alpha 2-delta . All of these cDNAs were inserted into the pMT2 expression vector (Stea et al., 1994). Chimeras were produced by a classical two-step PCR approach (Cens et al., 1998). beta TF1 and beta  chimera were finally digested using EcoRI and XbaI and subcloned into pBluescript (Stratagene, La Jolla, CA) before sequencing (DiDeoxy Terminator technology; Applied Biosystems, Foster City, CA). Constructs were subsequently subcloned into pMT2 for injection and expression.

Point mutants were obtained by PCR following commercial mutagenesis kit instructions (Quick Change site-directed mutagenesis kit; Stratagene) and using the following sense and antisense primers: beta 2C3,4S  AS, ATG TAC CAG CCC GGA GGA CTG CAT GAA GAG GTG G; beta 2 C3S AS, ATG TAC CAG CCC GCA GGA CTG CAT GAA GAG GTG G; beta 2 C4S AS, ATG TAC CAG CCC GGA GCA CTG CAT GAA GAG GTG G; beta 2R9-11A AS, GGA CAC CCG TAC TGC CGC GGC ATG TAC CAG CCC G; beta 2R10A  AS, CCG TAC TGC CGC GCG ATG TAC; and beta 2R13A  AS, CCA TAG GAC ACC GCT ACT CGC CGG.

For the chimera CD8-beta 2aC3,4S construction, the beta 2a was amplified from the pMT2 vector by PCR, using a forward primer containing the double cysteine mutation. The following primers were used: forward, 5'-CGCGGATCCCAGTCCTCCGGGCTGGTACATCGCCGGCGAGTACGG-3', and reverse, 5'-ACGTGAATTCTTGGCGGATGTATACATCCCTGTTCCACTCGCCGAC-3', containing BamHI or EcoRI restriction sites, respectively.

The PCR product was purified and subcloned in frame into the BamHI and EcoRI sites of the pcDNA3-CD8-beta ARK-Myc vector after removing the beta ARK insert. This vector was generously provided by Dr. J. Lang (Geneva University, Geneva, Switzerland).

In vitro translation and binding of glutathione S-transferase fusion proteins. 35S-labeled alpha 1A I-II loop was synthesized by coupled in vitro transcription and translation (TNT; Promega, Madison, WI). Purified glutathione S-transferase (GST) fusion proteins (250 nM each) were immobilized to glutathione agarose beads (Sigma-Aldrich, Saint Quentin Fallavier, France) by 30 min incubation in TBS (25 mM Tris and 150 mM NaCl, pH 7.4) and 0.1% Triton X-100. Binding was initiated by addition of the 35S-labeled alpha 1A I-II loop (2 µl), and this final mixture was incubated overnight at 4°C. Beads were washed four times with binding buffer, and associated 35S-labeled alpha 1A I-II loop was analyzed by SDS-PAGE and autoradiography.

Cell transfection and immunofluorescence. tsA 201 cells were maintained in DMEM (Life Technologies, Rockville, MD) containing 10% fetal bovine serum and 1% penicillin-streptomycin at 37°C in 5% CO2. Transfections were performed using Superfect according to the protocols of Qiagen (Hilden, Germany), 1 d after plating the cells on poly-L-ornithine-treated 35 mm Petri dishes. Plasmid cDNA(s) (5 µg) was used for each transfection with an incubation time of 2 hr. Forty-eight hours later, cells were fixed and permeabilized using PBS supplemented with 4% paraformaldehyde and 0.05% Triton X-100 (20 and 10 min, respectively). After an incubation of 1 hr in 3% PBS plus BSA, cells were incubated an additional 1 hr with the primary polyclonal antibody beta -com (Pichler et al., 1997), washed three times in PBS, and incubated 1 hr with the secondary anti-rabbit goat antibody conjugated to CY-3 (Sigma-Aldrich). After three other washes, cells were mounted and viewed on a conventional or a confocal immunofluorescent microscope. Confocal microscopy was performed at the CRIC (Center Régional d'Imagerie Cellulaire) facilities.

Xenopus oocyte preparation and injection. Xenopus oocyte preparation and injection (5-10 nl of alpha 1, alpha 1 plus beta , or alpha 1 plus alpha 2delta plus beta  cDNAs at ~ 0.3 ng/nl) were performed as described previously (Cens et al., 1996). Oocytes were then incubated for 2-7 d at 19°C under gentle agitation before recording.

Electrophysiological recordings. Whole-cell Ba2+ currents were recorded under two-electrode voltage clamp using a GeneClamp 500 amplifier (Axon Instruments, Burlingame, CA). Current and voltage electrodes (<1 MOmega ) were filled with CsCl 2.8 M and BAPTA 10 mM, pH 7.2 with CsOH. Ba2+ current recordings were performed after injection of BAPTA [~50 nl of (in mM): 100 BAPTA-free acid (Sigma-Aldrich), 10 CsOH, and 10 HEPES, pH 7.2 with CsOH using one or two 40-70 msec injection at 1 bar] in the following bath solution (in mM): 10 BaOH, 20 TEAOH, 50 NMDG, 2 CsOH, and 10 HEPES, pH 7.2 with methanesulfonic acid. Ba2+ current amplitudes were usually in the range of 1-5 µA. Currents were filtered and digitized using a DMA-Tecmar Labmaster (Tecmar Inc., Longmont, CO) and subsequently stored on a IPC 486 personal computer using version 6.02 of the pClamp software (Axon Instruments). Ba2+ currents were recorded during a typical 2.5 sec duration test pulse from -80 to +10 mV. Current amplitudes were measured at the peak of the current (I1) and at the end of the pulse (I2). The percentage of inactivation was calculated as the ratio (I1 - I2)/I1. Pseudo steady-state inactivation (2.5 sec of conditioning depolarization followed by a 400 msec test pulse to +10 mV) was fitted using the following equation:
I/I<SUB><UP>max</UP></SUB>=R+(1−R)/(1+<UP>exp</UP>((V−V<SUB>0.5</SUB>)/k))
where I is the current amplitude measured during the test pulse at +10 mV for conditioning depolarizations varying from -80 to +50 mV, Imax is the current amplitude measured during the test pulse for a conditioning depolarization of -80 mV, R is the proportion of non-inactivating current, V is the conditioning depolarization, V0.5 is the half-inactivation potential, and k is a slope factor. Similar inactivation curves were also performed using 7.5 sec conditioning depolarizations without significant differences in the calculated V0.5. All values are presented as mean ± SD of n determinations. A Student's t test was used at p = 0.05 to determine the significance of the difference between the two means.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Coexpression of the alpha 1A and alpha 2-delta subunits with the neuronal beta 1b in Xenopus oocytes resulted in a Ba2+ current that inactivated by >90% after 2.5 sec (93 ± 2%) (Fig. 1B). A similar experiment performed with the beta 2a subunit produced Ba2+ currents with very slow inactivation kinetics leading to only 40 ± 9% inactivation at the end of the pulse (Fig. 1). Because expression of the alpha 1A subunit alone gave currents with fast inactivation (Mangoni et al., 1997), we interpreted this slowing in the presence of the beta 2a subunit as a blocking of the normal inactivation mechanism. Moreover, the beta 1b subunit that provided rapidly inactivating currents (when expressed with the alpha 1A subunit) was localized throughout the cytoplasm (when expressed alone), whereas the beta 2a subunit that produced slow currents was localized close to the membrane (Fig. 1B). We and others have shown that the V1 domain of the beta 2a subunit (in which palmitoylation occurs) (Fig. 1) is the main determinant of the beta 2a subunit-induced regulation of voltage- and Ca2+-dependent inactivation, as well as of the inhibition of facilitation of the alpha 1C Ca2+ channel (Olcese et al., 1994; Cens et al., 1998, 1999a,b; Qin et al., 1998). However, although palmitoylation of the beta 2a subunit has been shown recently to be involved in both membrane association of the subunit and slowing of the inactivation kinetics, the causal relation between these phenomena has not been studied.



View larger version (62K):
[in this window]
[in a new window]
 
Figure 2.   Cys3 and Cys4 of beta 2 are major determinants for membrane localization and slow inactivation. A, Localization and nature of the different mutations made in the V1beta 2 domain. beta 2 refers to the wild-type sequence of the rat beta 2a subunit. B, Mutation of Cys(3,4) of the beta 2a subunit to Ser (labeled C3,4S in B) induced a marked increase in inactivation (n = 21) and a localization of the beta 2a subunit to the cytoplasm (see E). Mutation of Arg(9,10,11) to Ala (labeled R9-11A in Fig. 3B; n = 13) has a similar, albeit reduced in amplitude, effect: acceleration of the inactivation kinetics and cytoplasmic localization of the mutated beta 2a subunit (see E). Traces labeled beta 2 show current kinetics recorded with the wild-type beta 2a subunit (similar to trace labeled beta 2 in Fig. 1B) for comparison. * indicates statistically different from beta 2. C, Mutation of only one Cys to Ser (either Cys3, n = 14; or Cys4, n = 7; labeled C3S and C4S, respectively) is sufficient to produce an acceleration of current kinetics and a delocalization of the mutated beta 2a subunit to the cytoplasm (see E). * indicates statistically different from beta 2. D, However, mutation of only one Arg (either Arg(10)Ala, n = 19; or Arg(13)Ala, n = 9; labeled R10A and R13A, respectively) has no effect on current kinetics (left) and membrane localization (right) of the beta  subunit (E). E, Confocal immunofluorescent images of tsA 201 cells transfected with the different mutated beta 2a subunits.

Simultaneous mutations of Cys3 and Cys4 to Ser residues (designated beta 2C3,4S) (Fig. 2A) has been shown to prevent beta 2a subunit palmitoylation in Xenopus oocytes and to accelerate alpha 1E Ca2+ channel inactivation (Chien et al., 1998; Qin et al., 1998). When expressed in oocytes with the alpha 1A subunit, we also observed this increase in inactivation (87 ± 13% compared with 40% for beta 2a) (Fig. 2B). Figure 2E shows that expression of this mutated subunit was diffuse in the cytoplasm. Interestingly, expression of single Cys mutations of the beta 2a subunit, either Cys3 (beta 2C3S) or Cys4 (beta 2C4S), produced a similar effect on both the Ca2+ channel inactivation (85 ± 7 and 87 ± 17%, respectively) and the intracellular localization of the beta 2a subunit (Fig. 2E), suggesting that both Cys residues need to be present for a correct palmitoylation of the beta 2a subunit. Mutation of positively charged residues Arg10 and Arg13 of the beta 2a subunit (beta 2R10A and beta 2R13A, respectively) (Fig. 2D) had no effect on channel inactivation (30 ± 11 and 47 ± 20%) or on beta  subunit localization, which remained, for both mutations, membrane localized (Fig. 2E). However, when the three Arg residues at positions 9, 10, and 11 of the beta 2a subunit were replaced by Ala residues (mutant beta 2R9-11A) (Fig. 2), the membrane association of the beta 2a subunit was lost (Fig. 2B,E). Recordings of Ca2+ currents in the presence of this mutant showed that the inactivation kinetics of the alpha 1A Ca2+ channel were significantly faster than with the beta 2a subunit (51 ± 22%). Therefore, additional sites other than the two Cys are important for the proper membrane association and slowing of inactivation induced by the beta 2a subunit. If we postulate that membrane association of the beta 2a subunit, when expressed alone, was attributable to palmitoylation of Cys3 and Cys4, mutation R9-11A could affect either the formation and the stability of the thioester bond or the association with the plasma membrane through modification of electrostatic interactions as already shown in the case of Src (Murray et al., 1998). Indeed, the double mutant (beta 2C3,4S-R9-11A), which lacks both the two Cys residues and the three Arg residues (Fig. 2) and therefore cannot be palmitoylated, displayed current inactivation kinetics and subcellular localization identical to the beta C3,4S mutant (94 ± 2% and cytoplasm localization; data not shown).

Altogether, these data suggest that multiple sites can affect the palmitoylation level and the cellular localization of the beta 2a subunit. In all cases, however, the membrane localization of the beta  subunit was always associated with a marked slowing of the inactivation kinetics, suggesting that this feature represents a key element for slow inactivation. We tested this idea by forcing the membrane localization of the subunit by addition of a transmembrane segment at the N terminal tail of the double Cys-mutated beta  subunit. The resulting chimera (CD8-beta 2C3,4S) (Fig. 3A) possessed the transmembrane sequence of the CD8 protein in the N-terminal position. We expressed this chimeric protein in Xenopus oocytes along with the alpha 1A and alpha 2delta subunits for current recordings or alone in tsA 201 cells to study its cellular localization. As shown in Figure 3B, addition of the CD8 sequence produced a very marked slowing of the inactivation kinetics (33 ± 14% compared with 87 ± 12% to the beta 2C3,4S mutant). In other terms, the forced membrane localization of the protein restored a key regulation that is normally seen with the wild-type beta 2a subunit but not with the double Cys mutated form of the protein. This characteristic slowing in inactivation induced by the CD8-beta 2C3,4S chimera was quite expectedly correlated with a membrane association of the protein as detected by immunofluorescence staining using either an anti-beta (Fig. 3C) or an anti-CD8 antibody (data not shown). Similar results were found with the CH4 subunit, a chimeric beta 1 subunit with the first V1 domain replaced by the homologous domain of the beta 2 subunit. The slow current inactivation (Olcese et al., 1994) and membrane localization induced by CH4 (Fig. 3B) is only attributable to the V1 domain of beta 2, because a beta 1 subunit from which this domain has been deleted (beta 1TF1) kept its cytoplasmic localization and still induced fast inactivation (88 ± 4% of inactivation; data not shown). Thus, mutation of Cys3 and Cys4 in CH4 accelerates current inactivation and localizes the subunit to the cytoplasm, whereas addition of the CD8 segment restores both slow inactivation and membrane localization (Fig. 3B,C, CH4-C3,4S, CD8- CH4-C3,4S). The latter results suggest that the beta 2a subunit needs a membrane anchor to reduce channel inactivation.



View larger version (38K):
[in this window]
[in a new window]
 
Figure 3.   Addition of a membrane-spanning sequence at the N-terminal end of beta 2C3,4S slows inactivation. A, Schematic representation of the CD8 constructions. The ectomembrane and transmembrane domains of the CD8 receptor were fused to the N-terminal end of the beta 2C3,4S subunit, giving the chimeric CD8-beta 2C3,4S subunit. Similarly CD8-CH4-C3,4S was constructed using the mutated Cys3,4S CH4 chimera (in which the V1 domain of beta 1 was replaced by V1beta 2). B, Ba2+ currents recorded from oocytes expressing the alpha 1A and alpha 2-delta subunits with the beta 2C3,4S, the CD8-beta 2C3,4S, the CH4, the CH4-C3,4S, or the CD8-CH4-C3,4S subunits. Mutation Cys(3,4)Ser in beta 2 induced a rapidly inactivating currents (labeled C3,4S; n = 21), correlated with a cytoplasmic localization, as seen in Figure 3. Addition of the CD8 receptor transmembrane segment (CD8-beta 2C3,4S; n = 8) restored the slow inactivation typically seen with the wild-type beta 2a subunit. * indicates statistically different from beta 2C3,4S. Similar effects were found with the slowly-inactivating CH4 chimera (see right panel). C, Confocal images of a middle plane of tsA 201 cells expressing the various chimera and immunostained with an anti-beta antibody. After expression in cells, the CD8-beta 2C3,4S chimera was also targeted to the membrane as the slowly inactivating wild-type beta 2a, CH4, and CD8-CH4-C3,4S subunits. The CH4-C3,4S subunit was localized to the cytoplasm.

Another important feature of the alpha 1A channel properties recorded in the presence of the beta 2a subunit is the shift in inactivation toward more depolarized values. Analysis of the inactivation properties of channels expressed with a beta 2a subunit evidenced a depolarizing shift of ~10-20 mV in the half-inactivation potential (E0.5) compared with channels containing a beta 1 subunit. This difference was also found in our experimental conditions (BAPTA-injected oocytes) between oocytes expressing an alpha 1A plus alpha 2-delta plus beta 1b or alpha 1A plus alpha 2-delta plus beta 2a subunit combination (E0.5 of -32 ± 5 and -13 ± 6 mV for beta 1b and beta 2a, respectively) (Fig. 4) . beta  subunit constructs that induced slowly inactivating currents also shifted the E0.5 toward positive values (more than -20 mV) (Fig. 4, beta 2, beta CH4, R10A, R13A, CD8-beta 2C3,4S, CD8-CH4-C3,4S). Conversely, beta  subunits producing fast inactivation (beta 1b, beta  2C3,4S, beta  2C3S, and CH4-C3,4S) generated more hyperpolarized steady-state inactivation curves (E0.5 of less than -20 mV). Interestingly, expression of the beta 2R9-11A subunit, which induced currents characterized by a moderate percentage of inactivation, had an E0.5 value intermediate between those observed for the beta 1b and the beta 2a subunits. The beta 2C4S mutant was the only exception to this set of observations. The localization of this subunit was cytoplasmic and it induced rapidly inactivating currents (Fig. 3), but, contrary to expectations, the voltage dependence of inactivation was depolarized, similar to the beta 2a subunit (-16 ± 1 mV). However, we conclude that, overall, a strong correlation appears to exist between the ability of these subunits to induce currents with slow kinetics and depolarized inactivation and their membrane localization.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 4.   Membrane association of the beta  subunit shifts the steady-state inactivation relationship. Left, Typical steady-state inactivation curves recorded from oocytes expressing alpha 1A plus alpha 2-delta plus beta 1 (labeled beta 1) or alpha 1A plus alpha 2-delta plus beta 2 (labeled beta 2) subunits. Half-inactivation potentials were -32 and -12 mV for beta 1b and beta 2a, respectively. Right, Half-inactivation potentials obtained from oocytes expressing the alpha 1A plus alpha 2-delta subunits with different mutated or chimeric beta  subunits (n = 5-20). beta  subunits that induced slowly, beta 2a-like, inactivating currents induced depolarized half-inactivation potentials. Shadowed boxes underline the values and SDs of the half-inactivation potentials for beta 1b and beta 2a subunits.

We then analyzed the effects of the N terminal tail of beta 2a directly on Ca2+ channel inactivation. This was done by injecting, 4 hr before recording, the V1beta 2 peptide (corresponding to the first 16 amino acids of the beta 2a subunit) (Fig. 5) into oocytes expressing the alpha 1A, alpha 2-delta , and beta 1TF1 subunit combination. The final concentration of the peptide was estimated to be ~0.1 mM. Ba2+ currents recorded from both control noninjected and V1beta 2-injected oocytes inactivated rapidly, as seen on the superimposed traces and histograms in Figure 5 (94 ± 2 and 88 ± 4% for injected and control oocytes, respectively). Injection of the peptide therefore did not modify the inactivation kinetics of the currents, although the combined presence of beta 1TF1 and the V1beta 2 peptide mimicked the beta CH4 chimera, which produced slowly inactivating currents (Fig. 3). These results suggest that the presence of the N-terminal tail of beta 2 in the cell is not sufficient, by itself, to induce slowing of inactivation. A physical link between the membrane-anchored N-terminal tail of beta 2 (MAS) and the rest of the beta  subunit appears to be required to observe a slowing in inactivation. This link could be expected to restrict the mobility of the alpha 1 Ca channel I-II loop (AI-AII) (Fig. 6), which interacts directly with the beta  subunit. In these conditions, formation of the inactivated state of the channel may involve the binding of the I-II loop to a receptor site located on the intracellular side of the channel. We therefore searched for such potential interactions between the I-II loop and other intracellular domains of the channel. Different N- and C-terminal segments, as well as the II-III and the III-IV intracellular loops of the alpha 1A subunit, were constructed as GST fusion, produced, and purified (Fig. 6B, Coomassie blue-stained SDS-PAGE analysis of the GST fusion protein used). The different GST fusion proteins were then immobilized on glutathione agarose beads, incubated with in vitro-translated 35S-labeled alpha 1A I-II loop, washed, and analyzed by SDS-PAGE and autoradiography. As seen in Figure 6C, the alpha 1A I-II loop interacts with several intracellular domains, including the loop connecting domain III to IV (III-IV loop) and the N-terminal (NT6) and C-terminal (CT1, CT6) tails of the alpha 1 subunit. These sequences may thus be involved in the formation of the receptor site of the inactivation particle.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 5.   Perfusion of V1beta 2a peptide does not accelerate inactivation. We injected the V1beta 2a peptide (50 mM in H20; final intra oocyte concentration of ~0.1 mM; see Fig. 2A for sequence) into oocytes expressing the alpha 1A and alpha 2-delta subunit with the beta 1b subunit truncated in this V1 domain (beta 1TF1). The combination (V1beta 2a plus beta 1TF1) corresponds to the two parts of chimera beta -CH4, which induced slowly inactivating current when expressed with alpha 1A subunit. Currents were recorded during a typical test pulse to +10 mV in V1beta 2a-injected (n = 6) and noninjected oocytes (n = 12). No statistical differences were seen in the inactivation kinetics between these two batches of oocytes, indicating that the V1beta 2a peptide had no direct effect on channel inactivation.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 6.   The alpha 1A Ca channel I-II loop interacts with multiple intracellular domains of the channel. Schematic localization (A) and Coomassie blue-stained SDS-PAGE (B) of the purified GST proteins fused to N-terminal (NT1, NT4, NT5, NT6), C-terminal (CT1, CT3, CT6) or intracellular loop (AII-III, AIII-IV, AID) sequences of the alpha 1A subunit. C, Specific association of 35S-labeled I-II loop with N- and C-terminal sequences and III-IV loop of the channel. I, Input (2 µl of in vitro translated 35S-labeled I-II loop); GST, control GST.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Ca2+ channel inactivation influences not only cellular excitability but also different Ca-dependent pathways leading to contraction, secretion, synaptic activation, or gene transcription. A large number of mutational studies have pointed out the important role played by multiple elements of the alpha 1 pore-forming subunit on channel inactivation (Zhang et al., 1994; de Leon et al., 1995; Klockner et al., 1995; Parent et al., 1995; Adams and Tanabe, 1997; Herlitze et al., 1997; Sokolov et al., 1999; Spaetgens and Zamponi, 1999). It has been shown, for example, that the IS6, I-II loop, and C-terminal part of the alpha 1 subunit are critical determinants for inactivation kinetics (Zhang et al., 1994; Herlitze et al., 1997; Bourinet et al., 1999; Cens et al., 1999a; Spaetgens and Zamponi, 1999). Overall, these studies strongly suggest that several interactions occur between multiple structural motifs of the channel during the transition between the open and the inactivated states of the channel. Additionally, the beta  subunits have also been shown to be directly involved in the modulation of channel inactivation and are therefore likely to represent key components of the molecular mechanism that leads to channel inactivation.

Our first finding that palmitoylation of Cys3 and Cys4 of the beta 2a subunit is responsible for the beta 2a-induced slowing of inactivation of the P/Q type Ca2+ channel extends previous reports of the effects of beta 2a palmitoylation on alpha 1E and alpha 1C Ca2+ channels (Chien et al., 1996; Qin et al., 1998). The slowing of alpha 1A Ca2+ channel inactivation was correlated to a membrane localization of the beta 2a subunit when expressed alone in tsA 201 cells. Both effects were suppressed by mutation of a single Cys residue (3 or 4), showing for the first time that the two Cys residues are necessary for slowing inactivation and producing membrane localization. Similarly, whereas mutation of single positively charged residues (Arg to Ala) at positions 9 and 13 was without effect on channel inactivation (Fig. 2), similar mutations of the three contiguous Arg at positions 9-11 strongly reduced channel inactivation and membrane localization. This effect may arise from structural modifications in the N-terminal tail of beta 2a preventing subunit palmitoylation. Alternatively, electrostatic interactions between the acidic phospholipids and the cluster of basic residues could provide the energy necessary for membrane association of the subunit, as already shown for Src (Murray et al., 1998). In this case, hydrophobic and electrostatic interactions may act in synergy to target the beta 2a subunit to the membrane. Further experimental analysis of the level of palmitoylation of the beta 2R9-11A mutant will help to clarify the mechanism of targeting of the beta 2 subunit. However, it should be noted that the inactivation kinetics recorded with the beta 2R9-11A subunit, although being faster than those recorded with the wild-type beta 2a subunit, were still slower than with the nonpalmitoylated, cytoplasmically localized beta 2C3,4S subunit, suggesting that functional differences still exist between these two subunits. Our results define a minimal sequence (or MAS) for beta 2a subunit targeting, in which Cys3, Cys4, and adjacent Arg (10 and 12) are key residues: M-CC----R-R-.

Another important clue to understand the role of the beta 2a subunit in the modulation of inactivation is provided by the beta CH4 chimera. In the beta CH4 chimera, addition of the first 16 amino acids of beta 2a, in place of the V1 domain of beta 1b (Fig. 1A), induced palmitoylation (Chien et al., 1998), membrane localization of the chimera, and slowing of inactivation in coexpression experiments. This beta 2a-V1 sequence can therefore act as a MAS independently of any other beta 2a-specific sequences. However, effects of deletion of this MAS domain in the beta 2a subunit, which prevents palmitoylation, induces relocalization of the subunit to the cytoplasm, and acceleration of inactivation, are not compensated by injection of the V1 domain of beta 2a (Fig. 5). The latter results suggest that V1/MAS cannot act on its own to modulate channel inactivation but rather needs to be linked to a structural element common to beta 1 (see results with beta CH4) and beta 2a. One obvious candidate is the beta  interaction domain (BID) sequence (De Waard et al., 1994) located on C2, conserved in all beta  subunits, and directly responsible for the interaction between alpha 1 and beta  subunits. In our view, palmitoylation of Cys3,4 and binding to BID would act in concert to attenuate channel inactivation. The slowing in inactivation kinetics observed with the CD8-beta C3,4S and CD8-CH4C3,4S chimera suggests in fact that the role of palmitic acid is solely to provide an MAS to the beta  subunit because addition of a transmembrane segment appears equally effective. The direct involvement of the I-II loop of the alpha 1A subunit in channel inactivation (Herlitze et al., 1997; Bourinet et al., 1999; Spaetgens and Zamponi, 1999) leads us to propose that this sequence may behave as an inactivation particle, directly responsible for channel occlusion after opening. We suggest that, owing to its two functional domains, the beta 2a subunit acts as a molecular groom for the channel inactivation gate and immobilizes this inactivation particle by linking it to the membrane (Fig. 7). The model is compatible with the effect of the CD8-beta 2C3,4S chimera, the effects of mutation on the I-II loop, and the acceleration of alpha 1A channel inactivation recorded during overexpression of this loop (Cens et al., 1999a). Such an immobilization of the inactivation particle in the open configuration should increase the free energy necessary to reach the inactivated state. It is thus expected to shift the steady-state inactivation curve toward depolarized potential values. This effect is indeed recorded with the beta 2a subunit [half-inactivation potential (E0.5), 15 mV more depolarized than with beta 1] but also with its functional analog the CD8-beta 2C3,4S or the beta CH4 chimera. Conversely, release of the inactivation particle produces a shift of voltage-dependent inactivation toward more hyperpolarized potentials (see mutations beta 2C3,4S and beta 2C3S). The depolarized inactivation potential recorded with the rapidly inactivating beta 2C4S subunit cannot be explained in this context. This particular mutation may prevent inactivation occurring from the closed state of the channel as opposed to other rapidly inactivating channels, without modifying the stability of the inactivated state. Similar modifications have already been reported for mutated Na+ channels (Hartmann et al., 1994). The complete understanding of the effect of this mutation awaits recordings at the single-channel level and the knowledge of the palmitoylation state of all these mutant subunits.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 7.   Proposed mechanism for beta 2a-induced slowing of inactivation. In our scheme, the beta 2a subunit works as a rigid link between the membrane (via a palmitic acid anchor) and the inactivating particle (via its BID domain). When this link is broken (e.g., in mutation beta 2C3,4S, in a physiological situation producing a depalmitoylation, or in the case of a nonpalmitoylated beta  subunit), the inactivating particle (I-II loop) can move freely and produce the typical fast inactivation.

As expected, none of these mutations affected the interaction between the alpha 1A and the beta  subunit, because all are membrane localized when expressed with the alpha 1A subunit (data not shown). The GST pull-down experiment, shown in Figure 6, suggests multiple possible receptor sites for this inactivation particle. N-terminal and C-terminal sequences have already been shown to be involved in voltage- or calcium-dependent channel inactivation or regulation by beta  subunits. Interestingly, interaction of the I-II loop appears to be stronger with the III-IV loop, the most conserved connecting loop among high voltage-activated Ca channels (alpha 1A, alpha 1B, alpha 1C, and alpha 1E; >70% of similarity). These channels all display a slowing of inactivation by the beta 2a subunit. This loop is therefore a prime candidate for future studies on the inactivation mechanism, although other intracellular or intrapore domains may also directly participate in the process of inactivation.

The sensitivity of the thioester bond linking the palmitic acid to the beta 2a subunits makes this site a potentially important pathway for the regulation of Ca2+ entry into cells. Reducing agents or membrane receptor activation are known to modify the palmitoylated state of some signaling proteins (Galpha -protein and beta -adrenergic receptor) (Casey, 1995; Peterson and Catterall, 1995). Recently, nitrosylation by nitric oxide of thiol groups on cysteine residues of the beta -adrenergic receptor has been reported (Adam et al., 1999). Whether a similar pathway can affect palmitoylation of the beta 2a subunit in vivo is not known but could potentially be important in physiological or pathological situations during ischemia or oxidative stress, for example. This phenomena would be restricted to beta 2a-containing channels and would decrease calcium entry by promoting channel inactivation. In this respect, our results open new perspectives for further studies of the control of calcium channel inactivation by beta 2a subunits, in particular in their native cellular environment.


    FOOTNOTES

Received July 7, 2000; revised Sept. 29, 2000; accepted Oct. 13, 2000.

This work was supported by Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, the Association Française contre les Myopathies, the Association pour la Recherche contre le Cancer, the Fondation pour la Recherche Médicale, Ligue Nationale contre le Cancer, and the Groupe de Reflexion sur la Recherche Cardiovasulaire. We thank Drs. T. Snutch and E. Perez-Reyes for kindly providing calcium channel cDNAs, Dr. J. Streissnig for beta -com antibody, Drs. J. Mery and A. Chavanieux for peptide synthesis, and Drs. N. Morin, I. Lefèvre, A. Gouin-Charnet, J.-C. Labbé, and N. Lautredau (Centre for Research on Innovation and Competition) for invaluable technical help during the course of these experiments.

Correspondence should be addressed to Dr. Pierre Charnet, Centre de Recherches de Biochimie Macromoléculaire, Centre National de la Recherche Scientifique, Unité Propre de Recherche 1086, Institut Fédératif de Recherche 24, 1919 Route de Mende, 34293 Montpellier Cedex 05, France. E-mail: charnet{at}crbm.cnrs-mop.fr.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Adam L, Bouvier M, Jones TL (1999) Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling. J Biol Chem 274:26337-26343[Abstract/Free Full Text].
  • Adams B, Tanabe T (1997) Structural regions of the cardiac Ca channel alpha subunit involved in Ca-dependent inactivation. J Gen Physiol 110:379-389[Abstract/Free Full Text].
  • Berrow NS, Brice NL, Tedder I, Page KM, Dolphin AC (1997) Properties of cloned rat alpha1A calcium channels transiently expressed in the COS-7 cell line. Eur J Neurosci 9:739-748[Web of Science][Medline].
  • Birnbaumer L, Qin N, Olcese R, Tareilus E, Platano D, Costantin J, Stefani E (1998) Structures and functions of calcium channel beta subunits. J Bioenerg Biomembr 30:357-375[Web of Science][Medline].
  • Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, Zamponi GW, Nargeot J, Snutch TP (1999) Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci 2:407-415[Web of Science][Medline].
  • Casey PJ (1995) Protein lipidation in cell signaling. Science 268:221-225[Abstract/Free Full Text].
  • Cens T, Mangoni ME, Richard S, Nargeot J, Charnet P (1996) Coexpression of the beta2 subunit does not induce voltage- dependent facilitation of the class C L-type Ca channel. Pflügers Arch 431:771-774[Web of Science][Medline].
  • Cens T, Restituito S, Vallentin A, Charnet P (1998) Promotion and inhibition of L-type Ca2+ channel facilitation by distinct domains of the subunit. J Biol Chem 273:18308-18315[Abstract/Free Full Text].
  • Cens T, Restituito S, Galas S, Charnet P (1999a) Voltage and calcium use the same molecular determinants to inactivate calcium channels. J Biol Chem 274:5483-5490[Abstract/Free Full Text].
  • Cens T, Restituito S, Charnet P (1999b) Regulation of Ca-sensitive inactivation of a 1-type Ca2+ channel by specific domains of beta subunits. FEBS Lett 450:17-22[Web of Science][Medline].
  • Chien AJ, Carr KM, Shirokov RE, Rios E, Hosey MM (1996) Identification of palmitoylation sites within the L-type calcium channel beta2a subunit and effects on channel function. J Biol Chem 271:26465-26468[Abstract/Free Full Text].
  • Chien AJ, Gao T, Perez Reyes E, Hosey MM (1998) Membrane targeting of L-type calcium channels. Role of palmitoylation in the subcellular localization of the beta2a subunit. J Biol Chem 273:23590-23597[Abstract/Free Full Text].
  • de Leon M, Wang Y, Jones L, Perez Reyes E, Wei X, Soong TW, Snutch TP, Yue DT (1995) Essential Ca(2+)-binding motif for Ca(2+)-sensitive inactivation of L-type Ca2+ channels. Science 270:1502-1506[Abstract/Free Full Text].
  • De Waard M, Pragnell M, Campbell KP (1994) Ca2+ channel regulation by a conserved beta subunit domain. Neuron 13:495-503[Web of Science][Medline].
  • De Waard M, Witcher DR, Pragnell M, Liu H, Campbell KP (1995) Properties of the alpha 1-beta anchoring site in voltage- dependent Ca2+ channels. J Biol Chem 270:12056-12064[Abstract/Free Full Text].
  • Hartmann HA, Tiedeman AA, Chen SF, Brown AM, Kirsch GE (1994) Effects of III-IV linker mutations on human heart Na+ channel inactivation gating. Circ Res 75:114-122[Abstract/Free Full Text].
  • Herlitze S, Hockerman GH, Scheuer T, Catterall WA (1997) Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel alpha1A subunit. Proc Natl Acad Sci USA 94:1512-1516[Abstract/Free Full Text].
  • Jones LP, Wei SK, Yue DT (1998) Mechanism of auxiliary subunit modulation of neuronal alpha1E calcium channels. J Gen Physiol 112:125-143[Abstract/Free Full Text].
  • Klockner U, Mikala G, Varadi M, Varadi G, Schwartz A (1995) Involvement of the carboxyl-terminal region of the alpha 1 subunit in voltage-dependent inactivation of cardiac calcium channels. J Biol Chem 270:17306-17310[Abstract/Free Full Text].
  • Mangoni ME, Cens T, Dalle C, Nargeot J, Charnet P (1997) Characterisation of alpha1A Ba2+, Sr2+ and Ca2+ currents recorded with ancillary beta1-4 subunits. Receptors Channels 5:1-14[Web of Science][Medline].
  • Murray D, Hermida-Matsumoto L, Buser CA, Tsang J, Sigal CT, Ben Tal N, Honig B, Resh MD, McLaughlin S (1998) Electrostatics and the membrane association of Src: theory and experiment. Biochemistry 37:2145-2159[Medline].
  • Neely A, Wei X, Olcese R, Birnbaumer L, Stefani E (1993) Potentiation by the beta subunit of the ratio of the ionic current to the charge movement in the cardiac calcium channel. Science 262:575-578[Abstract/Free Full Text].
  • Olcese R, Qin N, Schneider T, Neely A, Wei X, Stefani E, Birnbaumer L (1994) The amino terminus of a calcium channel beta subunit sets rates of channel inactivation independently of the subunit's effect on activation. Neuron 13:1433-1438[Web of Science][Medline].
  • Parent L, Gopalakrishnan M, Lacerda AE, Wei X, Perez Reyes E (1995) Voltage-dependent inactivation in a cardiac-skeletal chimeric calcium channel. FEBS Lett 360:144-150[Web of Science][Medline].
  • Perez Reyes E, Schneider T (1994) Calcium channels: structure, function and classification. Drug Dev Res 33:295-318[Web of Science].
  • Perez Reyes E, Castellano A, Kim HS, Bertrand P, Baggstrom E, Lacerda AE, Wei XY, Birnbaumer L (1992) Cloning and expression of a cardiac/brain beta subunit of the L-type calcium channel. J Biol Chem 267:1792-1797[Abstract/Free Full Text].
  • Peterson BZ, Catterall WA (1995) Calcium binding in the pore of L-type calcium channels modulates high affinity dihydropyridine binding. J Biol Chem 270:18201-18204[Abstract/Free Full Text].
  • Pichler M, Cassidy TN, Reimer D, Haase H, Kraus R, Ostler D, Striessnig J (1997) Beta subunit heterogeneity in neuronal L-type Ca2+ channels. J Biol Chem 272:13877-13882[Abstract/Free Full Text].
  • Pragnell M, Sakamoto J, Jay SD, Campbell KP (1991) Cloning and tissue-specific expression of the brain calcium channel beta-subunit. FEBS Lett 291:253-258[Web of Science][Medline].
  • Pragnell M, De Waard M, Mori Y, Tanabe T, Snutch TP, Campbell KP (1994) Calcium channel beta-subunit binds to a conserved motif in the I- II cytoplasmic linker of the alpha 1-subunit. Nature 368:67-70[Medline].
  • Qin N, Platano D, Olcese R, Costantin JL, Stefani E, Birnbaumer L (1998) Unique regulatory properties of the type 2a Ca2+ channel beta subunit caused by palmitoylation. Proc Natl Acad Sci USA 95:4690-4695[Abstract/Free Full Text].
  • Randall A, Benam CD (1999) Recent advances in the molecular understanding of voltage-gated Ca2+ channels. Mol Cell Neurosci 14:255-272[Web of Science][Medline].
  • Sather WA, Tanabe T, Zhang JF, Mori Y, Adams ME, Tsien RW (1993) Distinctive biophysical and pharmacological properties of class A (BI) calcium channel alpha 1 subunits. Neuron 11:291-303[Web of Science][Medline].
  • Sokolov S, Weiss RG, Kurka B, Gapp F, Hering S (1999) Inactivation determinant in the I-II loop of the Ca2+ channel alpha1-subunit and beta-subunit interaction affect sensitivity for the phenylalkylamine (-)gallopamil. J Physiol (Lond) 519:315-322[Abstract/Free Full Text].
  • Spaetgens RL, Zamponi GW (1999) Multiple structural domains contribute to voltage-dependent inactivation of rat brain alpha(1E) calcium channels. J Biol Chem 274:22428-22436[Abstract/Free Full Text].
  • Starr TV, Prystay W, Snutch TP (1991) Primary structure of a calcium channel that is highly expressed in the rat cerebellum. Proc Natl Acad Sci USA 88:5621-5625[Abstract/Free Full Text].
  • Stea A, Dubel SJ, Pragnell M, Leonard JP, Campbell KP, Snutch TP (1993) A beta-subunit normalizes the electrophysiological properties of a cloned N-type Ca2+ channel alpha 1-subunit. Neuropharmacology 32:1103-1116[Web of Science][Medline].
  • Stea A, Tomlinson WJ, Soong TW, Bourinet E, Dubel SJ, Vincent SR, Snutch TP (1994) Localization and functional properties of a rat brain alpha 1A calcium channel reflect similarities to neuronal Q- and P-type channels. Proc Natl Acad Sci USA 91:10576-10580[Abstract/Free Full Text].
  • Varadi G, Lory P, Schultz D, Varadi M, Schwartz A (1991) Acceleration of activation and inactivation by the beta subunit of the skeletal muscle calcium channel. Nature 352:159-162[Medline].
  • Walker D, De Waard M (1998) Subunit interaction sites in voltage-dependent Ca2+ channels: role in channel function. Trends Neurosci 21:148-154[Web of Science][Medline].
  • Zhang JF, Ellinor PT, Aldrich RW, Tsien RW (1994) Molecular determinants of voltage-dependent inactivation in calcium channels. Nature 372:97-100[Medline].


Copyright © 2000 Society for Neuroscience  0270-6474/00/20249046-07$05.00/0


This article has been cited by other articles:


Home page
FASEB J.Home page
J.-P. Leyris, C. Gondeau, A. Charnet, C. Delattre, M. Rousset, T. Cens, and P. Charnet
RGK GTPase-dependent CaV2.1 Ca2+ channel inhibition is independent of CaV{beta}-subunit-induced current potentiation
FASEB J, August 1, 2009; 23(8): 2627 - 2638.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
M. L. Roberts-Crowley and A. R. Rittenhouse
Arachidonic acid inhibition of L-type calcium (CaV1.3b) channels varies with accessory CaV{beta} subunits
J. Gen. Physiol., April 1, 2009; 133(4): 387 - 403.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
F. Findeisen and D. L. Minor Jr.
Disruption of the IS6-AID Linker Affects Voltage-gated Calcium Channel Inactivation and Facilitation
J. Gen. Physiol., March 1, 2009; 133(3): 327 - 343.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Gonzalez-Gutierrez, E. Miranda-Laferte, D. Nothmann, S. Schmidt, A. Neely, and P. Hidalgo
The guanylate kinase domain of the {beta}-subunit of voltage-gated calcium channels suffices to modulate gating
PNAS, September 16, 2008; 105(37): 14198 - 14203.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
G. Gonzalez-Gutierrez, E. Miranda-Laferte, D. Naranjo, P. Hidalgo, and A. Neely
Mutations of Nonconserved Residues within the Calcium Channel {alpha}1-interaction Domain Inhibit {beta}-Subunit Potentiation
J. Gen. Physiol., September 1, 2008; 132(3): 383 - 395.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Chen and E. S. Piedras-Renteria
Altered frequency-dependent inactivation and steady-state inactivation of polyglutamine-expanded {alpha}1A in SCA6
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1078 - C1086.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. McDavid and K. P. M. Currie
G-Proteins Modulate Cumulative Inactivation of N-Type (CaV2.2) Calcium Channels
J. Neurosci., December 20, 2006; 26(51): 13373 - 13383.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. Haase, J. Alvarez, D. Petzhold, A. Doller, J. Behlke, J. Erdmann, R. Hetzer, V. Regitz-Zagrosek, G. Vassort, and I. Morano
Ahnak is critical for cardiac Ca(v)1.2 calcium channel function and its ss-adrenergic regulation
FASEB J, December 1, 2005; 19(14): 1969 - 1977.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Leroy, M. S. Richards, A. J. Butcher, M. Nieto-Rostro, W. S. Pratt, A. Davies, and A. C. Dolphin
Interaction via a Key Tryptophan in the I-II Linker of N-Type Calcium Channels Is Required for {beta}1 But Not for Palmitoylated {beta}2, Implicating an Additional Binding Site in the Regulation of Channel Voltage-Dependent Properties
J. Neurosci., July 27, 2005; 25(30): 6984 - 6996.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
S. Luvisetto, T. Fellin, M. Spagnolo, B. Hivert, P. F. Brust, M. M. Harpold, K. A. Stauderman, M. E. Williams, and D. Pietrobon
Modal Gating of Human CaV2.1 (P/Q-type) Calcium Channels: I. The Slow and the Fast Gating Modes and their Modulation by {beta} Subunits
J. Gen. Physiol., October 25, 2004; 124(5): 445 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. H Hurley, A. L Cahill, M. Wang, and A. P Fox
Syntaxin 1A regulation of weakly inactivating N-type Ca2+ channels
J. Physiol., October 15, 2004; 560(2): 351 - 363.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. Stotz, W. Barr, J. E. McRory, L. Chen, S. E. Jarvis, and G. W. Zamponi
Several Structural Domains Contribute to the Regulation of N-type Calcium Channel Inactivation by the {beta}3 Subunit
J. Biol. Chem., January 30, 2004; 279(5): 3793 - 3800.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. C. Stotz, S. E. Jarvis, and G. W. Zamponi
Functional roles of cytoplasmic loops and pore lining transmembrane helices in the voltage-dependent inactivation of HVA calcium channels
J. Physiol., January 15, 2004; 554(2): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. C. Dolphin
G Protein Modulation of Voltage-Gated Calcium Channels
Pharmacol. Rev., December 1, 2003; 55(4): 607 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. M Fitzgerald
The presence of ca2+ channel {beta} subunit is required for mitogen-activated protein kinase (mapk)-dependent modulation of {alpha}1b ca2+ channels in cos-7 cells
J. Physiol., September 1, 2002; 543(2): 425 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. M Colecraft, B. Alseikhan, S. X Takahashi, D. Chaudhuri, S. Mittman, V. Yegnasubramanian, R. S Alvania, D. C Johns, E. Marban, and D. T Yue
Novel functional properties of Ca2+ channel {beta} subunits revealed by their expression in adult rat heart cells
J. Physiol., June 1, 2002; 541(2): 435 - 452.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Geib, G. Sandoz, V. Cornet, K. Mabrouk, O. Fund-Saunier, D. Bichet, M. Villaz, T. Hoshi, J.-M. Sabatier, and M. De Waard
The Interaction between the I-II Loop and the III-IV Loop of Cav2.1 Contributes to Voltage-dependent Inactivation in a beta -Dependent Manner
J. Biol. Chem., March 15, 2002; 277(12): 10003 - 10013.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Shi and N. M. Soldatov
Molecular Determinants of Voltage-dependent Slow Inactivation of the Ca2+ Channel
J. Biol. Chem., February 22, 2002; 277(9): 6813 - 6821.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. S. Piedras-Renteria, K. Watase, N. Harata, O. Zhuchenko, H. Y. Zoghbi, C. C. Lee, and R. W. Tsien
Increased Expression of alpha 1A Ca2+ Channel Currents Arising from Expanded Trinucleotide Repeats in Spinocerebellar Ataxia Type 6
J. Neurosci., December 1, 2001; 21(23): 9185 - 9193.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M Rousset, T Cens, S Restituito, C Barrere, J L Black III, M W McEnery, and P Charnet
Functional roles of {gamma}2, {gamma}3 and {gamma}4, three new Ca2+ channel subunits, in P/Q-type Ca2+ channel expressed in Xenopus oocytes
J. Physiol., May 1, 2001; 532(3): 583 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Mouton, A. Feltz, and Y. Maulet
Interactions of Calmodulin with Two Peptides Derived from the C-terminal Cytoplasmic Domain of the Cav1.2 Ca2+ Channel Provide Evidence for a Molecular Switch Involved in Ca2+-induced Inactivation
J. Biol. Chem., June 15, 2001; 276(25): 22359 - 22367.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. Stotz and G. W. Zamponi
Identification of Inactivation Determinants in the Domain IIS6 Region of High Voltage-activated Calcium Channels
J. Biol. Chem., August 24, 2001; 276(35): 33001 - 33010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-P. Feng, M. I. Arnot, C. J. Doering, and G. W. Zamponi
Calcium Channel beta Subunits Differentially Regulate the Inhibition of N-type Channels by Individual Gbeta Isoforms
J. Biol. Chem., November 21, 2001; 276(48): 45051 - 45058.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (55)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Restituito, S.
Right arrow Articles by Charnet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Restituito, S.
Right arrow Articles by Charnet, P.

-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-